Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BIORA THERAPEUTICS, INC. (PROG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | | 6696.6% | 7897.7% | 7345.8% | | 9582.6% | 7422.7% |
| Sales and marketing | | | | | | 1626.2% | | |
| EBITDA | | | -12717.2% | -13122.6% | -11474.4% | -9384.6% | -15395.0% | -17832.6% |
| Depreciation | | | 154.5% | 123.1% | 110.7% | 115.2% | 157.5% | 203.8% |
| EBIT | | | -12871.8% | -13245.7% | -11585.1% | -9499.8% | -15552.5% | -18036.4% |
| Pre-tax income | | | -16383.6% | -17041.4% | -14799.4% | -14325.6% | -15853.7% | -17904.7% |
| Income taxes | | | -8303.6% | -7299.8% | -5021.5% | -3538.1% | 1630.5% | 3647.9% |
| Net income | | | -16158.1% | -18833.1% | -19288.6% | -19840.6% | -25061.8% | -29468.2% |
|